These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5815796)

  • 21. Objective determination of the bioavailability of dermocorticoids--influence of the formulation.
    Poelman MC; Leveque JL; Le Gall F
    Br J Dermatol; 1984 Jul; 111 Suppl 27():158-62. PubMed ID: 6743548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of the degree of dispersion and of the type of ointment base on the skin absorption of hydrocortisone and prednisolone ointments].
    Skripkin IuK; Dobrotvorskiĭ AE; Demidova NM; Aliushin MT
    Vestn Dermatol Venerol; 1974 May; 48(5):19-21. PubMed ID: 4839253
    [No Abstract]   [Full Text] [Related]  

  • 23. [Simultaneous determination of urea and hydrocortisone penetration into human skin].
    Wohlrab W
    Dermatol Monatsschr; 1990; 176(2-3):139-43. PubMed ID: 2365109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of 4 barrier creams on the absorption of water, benzene, and formaldehyde into excised human skin.
    Lodén M
    Contact Dermatitis; 1986 May; 14(5):292-6. PubMed ID: 3743039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimethylacetamide (DMAC) and dimethylformamide (DMFA). Effect on percutaneous absorption.
    Munro DD; Stoughton RB
    Arch Dermatol; 1965 Nov; 92(5):585-6. PubMed ID: 5844405
    [No Abstract]   [Full Text] [Related]  

  • 26. Percutaneous absorption of benzydamine in guinea pig and man.
    Andersson K; Larsson H
    Arzneimittelforschung; 1974 Oct; 24(10):1686-8. PubMed ID: 4479782
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ultraphonophoresis and its effect on the distribution and deposition of hydrocortisone 4-C-14 in experiments].
    Gatev SP; Pantev GP
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(1):42-5. PubMed ID: 5456680
    [No Abstract]   [Full Text] [Related]  

  • 28. Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome.
    Halverstam CP; Vachharajani A; Mallory SB
    Pediatr Dermatol; 2007; 24(1):42-5. PubMed ID: 17300648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the skin penetration properties of different carrier vehicles for topically applied cortisol.
    Ayres PJ; Hooper G
    Br J Dermatol; 1978 Sep; 99(3):307-17. PubMed ID: 708599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of DMSO on percutaneous penetration of hydrocortisone and testosterone in man.
    Maibach HI; Feldmann RJ
    Ann N Y Acad Sci; 1967 Mar; 141(1):423-7. PubMed ID: 5342260
    [No Abstract]   [Full Text] [Related]  

  • 31. Penetration of corticosteroids through the skin in relation to the vehicle.
    Ponec M
    Dermatologica; 1976; 152 Suppl 1():37-46. PubMed ID: 955237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The particle size of dexamethasone incorporated in ointments and its relation to the penetration of emulsion ointments into the horny layer of the skin in vivo].
    Kleine-Natrop HE
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(3):425-31. PubMed ID: 1024238
    [No Abstract]   [Full Text] [Related]  

  • 33. Percutaneous penetration of 14C hydrocortisone in man. II. Effect of certain bases and pretreatments.
    Feldmann RJ; Maibach HI
    Arch Dermatol; 1966 Nov; 94(5):649-51. PubMed ID: 5960372
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles.
    Coldman MF; Poulsen BJ; Higuchi T
    J Pharm Sci; 1969 Sep; 58(9):1098-102. PubMed ID: 5346073
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adrenal cortex hormone preparations. VIII. Absorption of hydrocortisone acetate from ointments by rabbit skin].
    Nerlo H; Umer S
    Acta Pol Pharm; 1983; 40(2):207-10. PubMed ID: 6659999
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical steroid therapy in skin disease. A panel discussion.
    S Afr Med J; 1974 Aug; 48(42):suppl:1-8. PubMed ID: 4278512
    [No Abstract]   [Full Text] [Related]  

  • 37. Vehicles based on a sugar surfactant: Colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation.
    Savić SD; Savić MM; Vesić SA; Vuleta GM; Müller-Goymann CC
    Int J Pharm; 2006 Aug; 320(1-2):86-95. PubMed ID: 16730932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical corticosteroids--an experimental evaluation of the vasoconstrictor test as an index of anti-inflammatory activity.
    Reid J; Brookes DB
    Br J Dermatol; 1968 May; 80(5):328-36. PubMed ID: 4873078
    [No Abstract]   [Full Text] [Related]  

  • 39. [Absorption of af 2071 (hydrocortisone-bendazac ester) after topical application compared with oral administration].
    Catanese B; Barillari G; Rossi V
    Boll Chim Farm; 1978 Jun; 117(6):368-74. PubMed ID: 743382
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of surfactants on percutaneous absorption of naproxen I: comparisons of rabbit, rat, and human excised skin.
    Chowhan ZT; Pritchard R
    J Pharm Sci; 1978 Sep; 67(9):1272-4. PubMed ID: 690833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.